{
    "2014-09-05": [
        "PCYC JNJ Imbruvica was the first orphan drug with fast-track, breakthrough, priority review, and accelerated approval in 2013",
        "Drug M&A Boom is Driven By Long-Term Trends: PwC. BMY CG JNJ THRX MNK TBPH",
        "The 5 largest S&P 500 companies: March 2000 vs September 2014: AAPL XOM MSFT JNJ WFC"
    ]
}